Literature DB >> 9574566

Dendritic cells as the terminal stage of monocyte differentiation.

K A Palucka1, N Taquet, F Sanchez-Chapuis, J C Gluckman.   

Abstract

Monocytes (MO) cultured for > or =5 days with either macrophage-CSF (M-CSF) or granulocyte macrophage (GM)-CSF and IL-4 differentiated without concomitant proliferation into CD14+ macrophages (Mphi) or CD1a+ dendritic cells (DC), respectively. When adherent and nonadherent CD14high Mphi from M-CSF cultures were separated and cultured further in cytokine-free medium or with GM-CSF/IL-4, most cells from both fractions that were exposed to GM-CSF/IL-4 acquired CD1a expression and DC morphology and function. Conversely, GM-CSF/IL-4 withdrawal at day 5 and additional culture of sorted CD1a+ DC for 2 to 7 days in cytokine-free medium led to cells rapidly becoming adherent CD1a-CD14+ Mphi. Replacing GM-CSF/IL-4 with M-CSF hastened the conversion of DC to Mphi without increasing cell numbers. CD1a+CD14-CD83+ mature DC were induced by a > or =2-day exposure to MO-conditioned medium, LPS, or TNF-alpha/IL-1beta. Upon cytokine removal or culture with M-CSF, DC that had been pushed to maturation by conditioned medium or LPS remained stable or died in the new environment. TNF-alpha/IL-1beta-driven DC displayed heterogeneous CD83 expression and could thus be sorted into CD83high and CD83low/- cells; in cytokine-free medium or in M-CSF, most CD83low/- cells converted to Mphi, whereas most CD83high cells remained nonadherent CD1a+CD14- or died and thus appeared truly terminally differentiated. Hence, MO are precursors of Mphi as well as of DC, with each cell type having the capability to convert into the other until late in the differentiation/maturation process. Accordingly, the cytokine environment and the presence of differentiation and/or other stimulatory signals may be the "final decision-making factors" determining whether these cells will acquire DC or Mphi characteristics and function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS).

Authors:  M E Duddy; G Dickson; S A Hawkins; M A Armstrong
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

Review 2.  Dendritic cells: a link between innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

3.  Potent immunoregulatory effects of Salmonella typhi flagella on antigenic stimulation of human peripheral blood mononuclear cells.

Authors:  T L Wyant; M K Tanner; M B Sztein
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies.

Authors:  R Jotwani; A K Palucka; M Al-Quotub; M Nouri-Shirazi; J Kim; D Bell; J Banchereau; C W Cutler
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy.

Authors:  Ulrike Kämmerer; Andreas O Eggert; Michaela Kapp; Alexander D McLellan; Teunis B H Geijtenbeek; Johannes Dietl; Yvette van Kooyk; Eckhart Kämpgen
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

6.  Simple chemicals can induce maturation and apoptosis of dendritic cells.

Authors:  H Manome; S Aiba; H Tagami
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

7.  Streptococcus gordonii promotes rapid differentiation of monocytes into dendritic cells through interaction with the sialic acid-binding adhesin.

Authors:  Yumiko Urano-Tashiro; Ayako Yajima; Yukihiro Takahashi; Kiyoshi Konishi
Journal:  Odontology       Date:  2011-10-18       Impact factor: 2.634

Review 8.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

Review 9.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

10.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

Authors:  M Colic; Z Stojic-Vukanic; B Pavlovic; D Jandric; I Stefanoska
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.